Investigating the Trends of Previous Ten Years Studies on Ataxia
Keywords:
Genetic Factors, Therapeutic Factors, Access to Healthcare, Ataxia PatientsAbstract
This review focuses on ataxia, a neurological illness that affects voluntary movements like walking, speech, and fine motor abilities due to a loss of muscle coordination. The study looks into the genetic causes and results of treatment for the many forms of ataxia, such as vestibular, cerebellar, and sensory ataxia, and access to healthcare facilities. It investigated the impact of environmental variables, rehabilitation therapies, and genetic predispositions. Prior research emphasized the part that neurodegenerative processes, autoimmune reactions, and genetic abnormalities play in the onset of ataxia. In order to provide a thorough understanding of the illness and possible treatment approaches, a systematic assessment of the literature from the previous 10 years was carried out to find patterns and gaps.
References
Ashizawa, T., Xia, G., & Taroni, F. (2018). Movement disorders: Advances in ataxia research—Closing the gaps. Nature Reviews Neurology, 14(9), 553-554.
D’Silva, A. M., Rowland, L. P., & Schiffmann, R. (2015). Advances in hereditary ataxia: New genetic causes and diagnostic challenges. Neurology, 84(4), 367-379.
Daker‐White, G., Kingston, H., Payne, K., Greenfield, J., Ealing, J., & Sanders, C. (2015). ‘You don't get told anything, they don't do anything and nothing changes’. Medicine as a resource and constraint in progressive ataxia. Health Expectations, 18(2), 177-187.
Dürr, A. (2010). Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. The Lancet Neurology, 9(9), 885-894.
Fonteyn, E. M., Schmitz-Hübsch, T., Verstappen, C. C., Baliko, L., Bloem, B. R., Boesch, S., ... & van de Warrenburg, B. P. (2014). Falls in spinocerebellar ataxias: Results of the EuroSCA fall study. Cerebellum & Ataxias, 1(1), 8.
Hadjivassiliou, M., Martindale, J., Shanmugarajah, P., Grünewald, R. A., Sarrigiannis, P. G., Beauchamp, N., ... & Hoggard, N. (2017). Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients. Journal of Neurology, Neurosurgery & Psychiatry, 88(4), 301-309.
Harding, A. E. (1993). Clinical features and classification of inherited ataxias. Brain, 116(1), 1-28.
Ilg, W., Synofzik, M., Brötz, D., Burkard, S., Giese, M. A., & Schöls, L. (2014). Intensive coordinative training improves motor performance in degenerative cerebellar disease. Neurology, 82(6), 512-519.
Jen, J. C. (2008). Episodic ataxia. Handbook of Clinical Neurology, 87, 161-171.
Klockgether, T. (2010a). Sporadic ataxia with adult onset: classification and diagnostic criteria. The Lancet Neurology, 9(1), 94-104.
Klockgether, T. (2010b). Update on degenerative ataxias. Current Opinion in Neurology, 23(4), 451-457.
Klockgether, T., Paulson, H. L., & Milunsky, A. (2019). Treatment and management of ataxia. Nature Reviews Neurology, 15(8), 449-462.
Kuo, S. H., Gan, S. R., Wang, J., Jankovic, J., & Ataxia Center Investigators. (2019). The patient’s journey to a diagnosis of spinocerebellar ataxia: Findings from a global registry. Parkinsonism & Related Disorders, 66, 104-109.
Manto, M. (2018). Cerebellar ataxias: New developments. Current Opinion in Neurology, 31(4), 462-471.
Manto, M., Huisman, T. A., & Solodkin, A. (2020). Cerebellar disorders: Challenges for clinical care, research, and education. The Cerebellum, 19(5), 621-622.
Matilla-Dueñas, A., Ashizawa, T., Brice, A., Magri, S., McFarland, K. N., Pandolfo, M., ... & Riess, O. (2014). Consensus paper: Pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias. The Cerebellum, 13(3), 269-302.
Milne, S. C., Corben, L. A., Georgiou-Karistianis, N., Delatycki, M. B., & Yiu, E. M. (2017). Rehabilitation for individuals with genetic degenerative ataxia: a systematic review. Neurorehabilitation and Neural Repair, 31(7), 609-622.
Müller, T., & Jahn, K. (2019). Barriers to healthcare access in rare neurodegenerative diseases: The case of hereditary ataxias. Orphanet Journal of Rare Diseases, 14(1), 225.
Pandolfo, M. (2009). Friedreich ataxia: The clinical picture. Journal of Neurology, 256(Suppl 1), 3-8.
Paulson, H. L., Shakkottai, V. G., Clark, H. B., & Orr, H. T. (2017). Polyglutamine spinocerebellar ataxias—From genes to potential treatments. Nature Reviews Neuroscience, 18(10), 613-626. https://doi.org/10.1038/nrn.2017.92
Schmitz-Hübsch, T., du Montcel, S. T., Baliko, L., Berciano, J., Boesch, S., Depondt, C., ... & Klockgether, T. (2010). Scale for the assessment and rating of ataxia (SARA) in different types of ataxia: A European multicentre study. Movement Disorders, 21(4), 1200-1205.
Strupp, M., Kalla, R., Dichgans, M., & Glasauer, S. (2011). Aminopyridines for the treatment of cerebellar and sensory ataxia. Progress in Brain Research, 191, 535-542.
Synofzik, M., & Ilg, W. (2014). Motor training in degenerative spinocerebellar disease: Ataxia-specific improvements in pilot randomized controlled trial. Neurodegenerative Diseases, 13(3), 89-98.
Tada, M., Nishizawa, M., & Onodera, O. (2016). Pathogenesis of cerebellar ataxias: Molecular mechanisms and therapeutic strategies. Brain and Nerve, 68(8), 891-899.
van de Warrenburg, B. P., van Gaalen, J., & Boesch, S. (2014). Diagnosis and differential diagnosis of ataxia syndromes. Neurology, 83(10), 927-932.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Mental Health
This work is licensed under a Creative Commons Attribution 4.0 International License.
